Kerim Chitour, MD, is the Global Head of Clinical for PATH’s Center for Vaccine Innovation and Access (CVIA), where he provides scientific and technical leadership for clinical development and pharmacovigilance activities across the PATH CVIA portfolio.
Before joining PATH in 2021, Kerim worked at Takeda Pharmaceuticals’ Vaccines Business Unit where, among other leadership roles, he was the Global Program Leader for the company’s Sabin inactivated poliovirus vaccine.
Prior to that, he held various leadership roles with Novartis Vaccines and Diagnostics, most recently serving as Chief Medical Officer for the Middle East and Africa. In this role, Kerim was responsible for establishing and leading the vaccines clinical development group in South Africa and Malawi. Earlier in his career, he held positions of increasing seniority with SmithKline Beecham Biologicals, Wyeth Vaccines, Chiron Vaccines, and Maxygen.
As an industry physician with more than 25 years of international experience with pharmaceutical and biotechnology companies, Kerim’s expertise lies in global clinical development and operations, team building, and partnership management.